Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuele Crespan

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
European Journal of Medicinal Chemistry|September 5, 2020
New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strainsMarianna Nalli, Jorge I Armijos Rivera, Domiziana Masci, et al.
Journal of Medicinal Chemistry|June 20, 2017
Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 AgentsValeria Famiglini, Giuseppe La Regina, Antonio Coluccia, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 9, 2025
Exploring structure-activity relationships of pyrrolyl diketo acid derivatives as non-nucleoside inhibitors of terminal deoxynucleotidyl transferase enzymeValentina Noemi Madia, Nadia Garibaldi, Davide Ialongo, et al.
Journal of Medicinal Chemistry|November 25, 2014
Indolylarylsulfones carrying a heterocyclic tail as very potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitorsValeria Famiglini, Giuseppe La Regina, Antonio Coluccia, et al.
Journal of Medicinal Chemistry|November 16, 2019
Multitarget CFTR Modulators Endowed with Multiple Beneficial Side Effects for Cystic Fibrosis Patients: Toward a Simplified Therapeutic Approach †Sabrina Tassini, Emily Langron, Leen Delang, et al.
International Journal of Molecular Sciences|March 6, 2021
A Role for Human DNA Polymerase λ in Alternative Lengthening of TelomeresElisa Mentegari, Federica Bertoletti, Miroslava Kissova, et al.
Archiv Der Pharmazie|January 28, 2025
Synthesis and biological investigation of peptidomimetic SARS-CoV-2 main protease inhibitors bearing quinoline-based heterocycles at P<sub>3</sub>Sara Rossi, Graziano Deidda, Lia Fiaschi, et al.
Journal of Medicinal Chemistry|December 12, 2018
Effect of α-Methoxy Substitution on the Anti-HIV Activity of Dihydropyrimidin-4(3 H)-onesMaxim B Nawrozkij, Mariantonietta Forgione, Alexandre S Yablokov, et al.
Journal of Medicinal Chemistry|April 30, 2015
Studies on the ATP Binding Site of Fyn Kinase for the Identification of New Inhibitors and Their Evaluation as Potential Agents against Tauopathies and TumorsCristina Tintori, Giuseppina La Sala, Giulia Vignaroli, et al.
Journal of Medicinal Chemistry|January 16, 2016
Discovery of the First Potent and Selective Inhibitors of Human dCTP Pyrophosphatase 1Sabin Llona-Minguez, Andreas Höglund, Sylvain A Jacques, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
European Journal of Medicinal Chemistry|September 5, 2020
New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strainsMarianna Nalli, Jorge I Armijos Rivera, Domiziana Masci, et al.
Journal of Medicinal Chemistry|June 20, 2017
Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 AgentsValeria Famiglini, Giuseppe La Regina, Antonio Coluccia, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 9, 2025
Exploring structure-activity relationships of pyrrolyl diketo acid derivatives as non-nucleoside inhibitors of terminal deoxynucleotidyl transferase enzymeValentina Noemi Madia, Nadia Garibaldi, Davide Ialongo, et al.
Journal of Medicinal Chemistry|November 25, 2014
Indolylarylsulfones carrying a heterocyclic tail as very potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitorsValeria Famiglini, Giuseppe La Regina, Antonio Coluccia, et al.
Journal of Medicinal Chemistry|November 16, 2019
Multitarget CFTR Modulators Endowed with Multiple Beneficial Side Effects for Cystic Fibrosis Patients: Toward a Simplified Therapeutic Approach †Sabrina Tassini, Emily Langron, Leen Delang, et al.
International Journal of Molecular Sciences|March 6, 2021
A Role for Human DNA Polymerase λ in Alternative Lengthening of TelomeresElisa Mentegari, Federica Bertoletti, Miroslava Kissova, et al.
Archiv Der Pharmazie|January 28, 2025
Synthesis and biological investigation of peptidomimetic SARS-CoV-2 main protease inhibitors bearing quinoline-based heterocycles at P<sub>3</sub>Sara Rossi, Graziano Deidda, Lia Fiaschi, et al.
Journal of Medicinal Chemistry|December 12, 2018
Effect of α-Methoxy Substitution on the Anti-HIV Activity of Dihydropyrimidin-4(3 H)-onesMaxim B Nawrozkij, Mariantonietta Forgione, Alexandre S Yablokov, et al.
Journal of Medicinal Chemistry|April 30, 2015
Studies on the ATP Binding Site of Fyn Kinase for the Identification of New Inhibitors and Their Evaluation as Potential Agents against Tauopathies and TumorsCristina Tintori, Giuseppina La Sala, Giulia Vignaroli, et al.
Journal of Medicinal Chemistry|January 16, 2016
Discovery of the First Potent and Selective Inhibitors of Human dCTP Pyrophosphatase 1Sabin Llona-Minguez, Andreas Höglund, Sylvain A Jacques, et al.
Pageof 10